Thyroid Diseases Completed Phase 2 Trials for Protirelin (DB09421)

Also known as: Thyroid Disease

IndicationStatusPhase
DBCOND0030067 (Thyroid Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00054756Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary AbnormalitiesDiagnostic